These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22809538)

  • 1. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator.
    Denollet J; Tekle FB; Pedersen SS; van der Voort PH; Alings M; van den Broek KC
    Int J Cardiol; 2013 Sep; 167(6):2705-9. PubMed ID: 22809538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
    Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
    Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.
    Seegers J; Conen D; Jung K; Bergau L; Dorenkamp M; Lüthje L; Sohns C; Sossalla ST; Fischer TH; Hasenfuss G; Friede T; Zabel M
    Europace; 2016 Aug; 18(8):1194-202. PubMed ID: 26622054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Ahn C; Tsai FS; Lai HM; Gandhi K; Amin H; Frishman WH; Kalapatapu K; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):37-40. PubMed ID: 19966176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of inappropriate defibrillator shocks in a population cohort.
    Deyell MW; Qi A; Chakrabarti S; Yeung-Lai-Wah JA; Tung S; Khoo C; Bennett MT; Qian H; Kerr CR
    Heart; 2013 Sep; 99(17):1250-5. PubMed ID: 23468515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shocks, personality, and anxiety in patients with an implantable defibrillator.
    Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.
    Desai H; Aronow WS; Ahn C; Gandhi K; Hussain S; Lai HM; Sharma M; Frishman WH; Cohen M; Sorbera C
    Am J Cardiol; 2010 May; 105(9):1336-8. PubMed ID: 20403488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
    Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.